27511-79-1,
3-Amino-4-pyrazolecarboxamide hemisulfate,
5-Aminopyrazole-4-carboxamide hemisulphate,
3-Amino-1H-pyrazole-4-carboxamide Hemisulfate,
3-Amino-1H-pyrazole-4-carboxamide sulfate(2:1),
1H-Pyrazole-4-carboxamide, 3-amino-, sulfate (2:1),
3-Amino-4-pyrazolecarboxamide hemisulfate salt,
MFCD00013093,
3-Aminopyrazole-4-carboxamide Hemisulfate,
5-amino-1H-pyrazole-4-carboxamide; sulfuric acid,
EINECS 248-503-6,
PubChem14012,
AC1MC3UU,
EC 248-503-6,
CTK4G9607,
DTXSID90181933,
C4H6N4O.0.5H2SO4,
UMPKASYMNORSRO-UHFFFAOYSA-N,
ACT01774,
EBD13089,
CA-156,
AKOS005258529,
AKOS030504524,
CS-W009403,
SB10163,
3-Amino-4-pyrazolecarbosamide hemisulfate,
AC-16100,
AK-46636,
AN-14650,
AS-15536,
BR-46636,
P782,
SC-46499,
SY020966,
AB0017205,
ST2410417,
TL8002214,
A5327,
FT-0614907,
3-Amino-1H-pyrazole-4-carboxamide sulfate(2,
MFCD00013093 (98%),
5-Amino-1H-pyrazole-4-carboxamide Hemisulphate,
M-6538,
5-amino-1H-pyrazole-4-carboxamide;sulfuric acid,
5-AMINO-4-PYRAZOLECARBOXAMIDE-HEMISULFATE,
511A791,
bis(3-amino-1H-pyrazole-4-carboxamide); sulfuric acid,
bis(3-amino-2H-pyrazole-4-carboxamide); sulfuric acid,
Allopurinol Related Compound A, United States Pharmacopeia (USP) Reference Standard,
Allopurinol Related Compound A, Pharmaceutical Secondary Standard; Certified Reference Material,
5-amino-1h-pyrazole-4-carboxamide,
C4H6N4O.1/2H2O4S,
CID2723907,
CS-O-07140,
3-Amino-4-carbamoylpyrazole Hemisulfate,
3-Aminopyrazole-4-carboxamide hemisulphate,
C4-H6-N4-O.1/2H2-O4-S,
A1532,
1h-pirazol-4-carboxamida, 3-amino-, sulfato (2:1),
1h-pyrazole-4-carboxamide, 3-amino-, sulfate(2:1),
Pyrazole-4-carboxamide 3-amino-sulfate (2:1) (8CI),
3-Amino-4-pyrazolecarboxamide hemisulfate, 98% - 1G 1g,
3-Amino-4-pyrazolecarboxamide/3-Amino-4-carbamoylpyrazole Hemisulfate,
329351-43-1,